Sale!

WISP3 Gene Arthropathy Progressive Pseudorheumatoid of Childhood Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The WISP3 gene arthropathy, also known as Progressive Pseudorheumatoid Dysplasia (PPD) or Progressive Pseudorheumatoid Arthropathy of Childhood, is a rare genetic disorder characterized by the progressive deterioration of articular cartilage, leading to joint stiffness, pain, and swelling. Unlike juvenile idiopathic arthritis, PPD does not involve autoimmune inflammation. Instead, it is caused by mutations in the WISP3 gene, which is crucial for the health and maintenance of cartilage tissue.

To diagnose this condition, genetic testing is essential. DNA Labs UAE offers a specialized genetic test aimed at detecting mutations in the WISP3 gene. This test is crucial for confirming the diagnosis of PPD, distinguishing it from other forms of juvenile arthritis, and guiding treatment and management plans.

The cost of the WISP3 gene arthropathy genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the WISP3 gene. Results from this test can provide valuable information for affected individuals and their families, including the confirmation of the diagnosis, prognosis, and the possibility of genetic counseling for future family planning.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

WISP3 Gene Arthropathy progressive pseudorheumatoid of childhood Genetic Test

Test Details

The WISP3 gene is associated with a rare genetic disorder called progressive pseudorheumatoid arthropathy of childhood (PPAC). PPAC is characterized by progressive joint stiffness, pain, and swelling, which can lead to joint deformities and limited mobility.

NGS (Next-Generation Sequencing) genetic testing can be used to identify mutations or variations in the WISP3 gene that are responsible for PPAC. NGS is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes or even the entire exome (the protein-coding region of the genome).

NGS genetic testing for WISP3 gene mutations can help confirm a diagnosis of PPAC and guide treatment decisions. It can also be used for carrier testing in families with a history of PPAC, as it is an autosomal recessive disorder.

Test Name

WISP3 Gene Arthropathy progressive pseudorheumatoid of childhood Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test type

Osteology Dermatology Immunology Disorders

Doctor

Dermatologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for WISP3 Gene Arthropathy, progressive pseudorheumatoid, of childhood NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WISP3 Gene Arthropathy, progressive pseudorheumatoid, of childhood NGS Genetic DNA Test gene WISP3

Test Name WISP3 Gene Arthropathy progressive pseudorheumatoid of childhood Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for WISP3 Gene Arthropathy, progressive pseudorheumatoid, of childhood NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WISP3 Gene Arthropathy, progressive pseudorheumatoid, of childhood NGS Genetic DNA Test gene WISP3
Test Details

The WISP3 gene is associated with a rare genetic disorder called progressive pseudorheumatoid arthropathy of childhood (PPAC). PPAC is characterized by progressive joint stiffness, pain, and swelling, which can lead to joint deformities and limited mobility.

NGS (Next-Generation Sequencing) genetic testing can be used to identify mutations or variations in the WISP3 gene that are responsible for PPAC. NGS is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes or even the entire exome (the protein-coding region of the genome).

NGS genetic testing for WISP3 gene mutations can help confirm a diagnosis of PPAC and guide treatment decisions. It can also be used for carrier testing in families with a history of PPAC, as it is an autosomal recessive disorder.